{
  "nctId": "NCT05583916",
  "briefTitle": "Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery",
  "officialTitle": "Phase I Safety and Feasibility Pilot Study of Same-Day Discharge After Video-Assisted Thoracoscopic Surgery (VATS) Anatomical Lung or Wedge Resection (VALUE Trial)",
  "protocolDocument": {
    "nctId": "NCT05583916",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2022-07-27",
    "uploadDate": "2022-10-05T17:02",
    "size": 1586157,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05583916/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 20,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2022-09-07",
    "completionDate": "2023-10",
    "primaryCompletionDate": "2023-10",
    "firstSubmitDate": "2022-10-04",
    "firstPostDate": "2022-10-18"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Signed or verbal informed consent by participant\n* Male and female adults, age 18 and above\n* Clinical stage I-II lung cancer (suspected, proven, unproven), or secondary pulmonary malignancy\n* BMI \\< 35\n* ECOG 0-1\n* Eligible for surgery and lung cancer resection (FEV1 \\> 60%, DLCO \\> 60%)\n* Elective VATS anatomic resection (segmentectomy or lobectomy), or wedge resection\n* Capable caregiver for discharge home\n\nExclusion Criteria:\n\n* Clinical stage III lung cancer\n* Surgery requiring pneumonectomy\n* Neoadjuvant therapy\n* Active pregnancy or breastfeeding\n* History of chronic pain syndromes\n* History of chronic opioid use\n* Concomitant major surgery indicated with current admission to hospital\n* Anticipated intraoperative complication including conversion to thoracotomy, major bleeding requiring blood transfusion, extensive adhesiolysis, injury to mediastinal structures, airway injury, nerve injury (phrenic, recurrent)\n* Need for epidural or patient-controlled intravenous analgesia\n* Need for urinary catheter",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Adverse Event Rate",
        "timeFrame": "30 days post surgery"
      },
      {
        "measure": "Same Day Discharge Rate",
        "timeFrame": "Throughout the trial, from start until completion of surgery for all the patients, up to 12 months."
      },
      {
        "measure": "Readmission Rate",
        "timeFrame": "30 days post surgery"
      },
      {
        "measure": "Rate of presentation to the emergency room after surgery",
        "timeFrame": "30 days post surgery"
      }
    ],
    "secondary": [
      {
        "measure": "Edmonton Symptom Assessment Scale (ESAS)",
        "description": "Rating pain, fatigue, nausea, depression, anxiety, drowsiness, appetite, well-being and shortness of breath, on a scale of 1 to 10. Higher scores indicate more serious symptoms.",
        "timeFrame": "30 days post surgery"
      },
      {
        "measure": "Functional Assessment of Cancer Therapy - Lung (FACT-L)",
        "description": "Rating questions regarding physical, social/family, emotion and function well-being as well as general questions regarding medical health, on a scale of 0-4 (from 'Not at all' to 'Very much').",
        "timeFrame": "30 days post surgery"
      },
      {
        "measure": "Duration of indwelling chest tube catheter",
        "timeFrame": "30 days post surgery or until the chest tube is removed (whichever comes last, assessed until 90 days post surgery)"
      },
      {
        "measure": "Rate of screen failure",
        "description": "Feasibility calculation of the number of patients approached to participate compared to the number of patients consented to the trial.",
        "timeFrame": "From trial start until last patient consented, up to 12 months."
      },
      {
        "measure": "Percent of eligible participants consented",
        "timeFrame": "From trial start until last patient consented, up to 12 months."
      },
      {
        "measure": "Pathway adherence rate",
        "description": "Calculation of the number of participants who stay on the same-day discharge pathway versus number of patients who deviate from the protocol.",
        "timeFrame": "From moment of consent until 1 day post surgery."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 4,
      "secondaryCount": 6,
      "otherCount": 0,
      "totalCount": 10
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 74,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:58.342Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}